Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

被引：0
|
作者：
Sola, MC
Christensen, RD
Hutson, AD
Tarantal, AF
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Calif Reg Primate Res Ctr, Davis, CA USA
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
D O I：
10.1203/00006450-199904020-01575
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1558
引用
收藏
页码：265A / 265A
页数：1
相关论文
共 50 条
  • [11] In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice
    Kabaya, K
    Akahori, H
    Shibuya, K
    Nitta, Y
    Ida, M
    Kusaka, M
    Kato, T
    Miyazaki, H
    STEM CELLS, 1996, 14 (06) : 651 - 660
  • [12] Pharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humans
    De Boer, RH
    Roskos, LK
    Cheung, E
    Fox, S
    Basser, RL
    Marty, J
    Begley, CG
    Cebon, J
    GROWTH FACTORS, 2000, 18 (03) : 215 - 226
  • [13] The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor on megakaryopoiesis in patients with aplastic anaemia
    Adams, JA
    Brereton, ML
    Briggs, M
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 62 - 62
  • [14] Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
    Powell, J. S.
    Nugent, D. J.
    Harrison, J. A.
    Soni, A.
    Luk, A.
    Stass, H.
    Gorina, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (02) : 277 - 283
  • [15] Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice
    Kabaya, K
    Shibuya, K
    Torii, Y
    Nitta, Y
    Ida, M
    Akahori, H
    Kato, T
    Kusaka, M
    Miyazaki, H
    BONE MARROW TRANSPLANTATION, 1996, 18 (06) : 1035 - 1041
  • [16] The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia
    Brereton, ML
    Adams, JA
    Briggs, M
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) : 119 - 126
  • [17] Long-term efficacy of pegylated recombinant human megakaryocyte growth and development factor in therapy of aplastic anemia
    Yonemura, Y
    Miyake, H
    Asou, N
    Mitsuya, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (04) : 307 - 309
  • [18] Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor
    Harker, LA
    Marzec, UM
    Novembre, F
    Sundell, IB
    Waller, EK
    Karpatkin, S
    McClure, HM
    Kelly, AB
    Stead, RB
    BLOOD, 1998, 91 (12) : 4427 - 4433
  • [19] Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice
    Shibuya, K
    Akahori, H
    Takahashi, K
    Tahara, E
    Kato, T
    Miyazaki, H
    BLOOD, 1998, 91 (01) : 37 - 45
  • [20] Long-term Efficacy of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Therapy of Aplastic Anemia
    Yuji Yonemura
    Hirosada Miyake
    Norio Asou
    Hiroaki Mitsuya
    International Journal of Hematology, 2005, 82 : 307 - 309
12345